MM

Muhamed Mustafa Parakkallil

Active Director Designated Partner DIN 11859321
DIN 11859321 First appointment Jul 2026
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2026
Shareholding value β€’β€’β€’β€’ Premium profile

About Muhamed Mustafa Parakkallil

Muhamed Mustafa Parakkallil is a Designated Partner at Acero Pharma Llp (since 2026).

DIN 11859321
Primary Designation Designated Partner
First Appointment 29 Jul 2026

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Acero Pharma Llp ADA-6439
Designated Partner29 Jul 20262026Active

Board colleagues of Muhamed Mustafa Parakkallil

NameDINCompanyDesignation
Hussain11859320Acero Pharma LlpDesignated Partner
Noushad11859319Acero Pharma LlpDesignated Partner
Kuttikkadan Majeed08802536Acero Pharma LlpDesignated Partner
Maruthampara Aboobacker11859322Acero Pharma LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Acero Pharma Llp
Premium access

Shareholding and investment profile for Muhamed Mustafa Parakkallil

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Muhamed Mustafa Parakkallil

Muhamed Mustafa Parakkallil currently holds 1 directorship: Acero Pharma Llp (Designated Partner, since 29 Jul 2026).

Muhamed Mustafa Parakkallil was first appointed on 29 Jul 2026 as Designated Partner at Acero Pharma Llp.

The current boards of Muhamed Mustafa Parakkallil's companies include Hussain (Acero Pharma Llp), Noushad (Acero Pharma Llp), Kuttikkadan Majeed (Acero Pharma Llp), Maruthampara Aboobacker (Acero Pharma Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available